Skip to main content
logo
KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,000.00
+300.00 (3.90%)
At close: Sep 4, 2026

KOREA PHARMA Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-773.54-2,6403,79283.76-1,1196,368
Depreciation & Amortization
3,0803,1672,7972,8132,3802,377
Loss (Gain) From Sale of Assets
-1.22-1.22-1.14-0.32-81.9-5.29
Asset Writedown & Restructuring Costs
222.4222.4279.24606.42--
Loss (Gain) From Sale of Investments
-321.56-748.22-364.1-1,91042.2-1.93
Loss (Gain) on Equity Investments
470.78278.05-1,6441,724--
Provision & Write-off of Bad Debts
62.8-33.47-187.6214.09103.16-157.11
Other Operating Activities
5,6524,8557,7974,8568,4361,440
Change in Accounts Receivable
-1,5901,153-701.761,1111,322-1,140
Change in Inventory
-1,832-5,111-1,436-1,254-381.272,613
Change in Accounts Payable
879.71-690.7799.42189.93376.94-1,969
Change in Other Net Operating Assets
2,5252,236-2,383-3,613-2,798-2,333
Operating Cash Flow
8,3742,6878,0464,8198,2797,192
Operating Cash Flow Growth
120.84%-66.61%66.95%-41.79%15.11%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-664.31-19,644-3,249-1,531-2,465-2,552
Sale of Property, Plant & Equipment
27.2727.271.07-215.415.3
Sale (Purchase) of Intangibles
-265.3-81.2-552.2-1,146-287.14-897.72
Investment in Securities
4,77711,918-8,53547,476-49,239-8,464
Other Investing Activities
000-0--
Investing Cash Flow
3,875-7,779-12,33544,899-51,875-12,908

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---4,000--
Long-Term Debt Issued
-16,0004,00023,000-49,997
Total Debt Issued
19,00016,0004,00027,000-49,997
Short-Term Debt Repaid
----4,000-3,000-3,000
Long-Term Debt Repaid
--4,723-18,751-39,112-1,018-1,089
Total Debt Repaid
-22,694-4,723-18,751-43,112-4,018-4,089
Net Debt Issued (Repaid)
-3,69411,277-14,751-16,112-4,01845,908
Dividends Paid
-545.34-545.34-545.34-545.34-545.34-545.34
Other Financing Activities
197.63-0--3.43--
Financing Cash Flow
-4,04210,732-15,296-16,661-4,56345,363

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
146.27-17.8769.72-23.449.3628.69
Net Cash Flow
8,3535,621-19,51633,034-48,15039,675

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,709-16,9574,7973,2885,8154,640
Free Cash Flow Growth
--45.87%-43.45%25.31%-
Free Cash Flow Margin
8.21%-19.36%5.90%3.95%7.18%5.83%
Free Cash Flow Per Share
699.91-1417.96440.24314.06535.19421.87
Levered Free Cash Flow
5,180-16,9642,639-1,6931,3951,004
Unlevered Free Cash Flow
7,488-14,7354,439642.873,8121,571

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
590.15504.12268.17312.67219.12159.93
Cash Income Tax Paid
82.3903.71202.812,297348.39-354.44
Change in Working Capital
-17.43-2,412-4,421-3,567-1,481-2,829